Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Hemophilia B Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Amarna Therapeutics
UniQure
Dimension Therapeutics
Alnylam Pharmaceuticals
Asklepios
Baxter
Spark Therapeutics
Novo Nordisk
REVO Biologics
Kedrion
Emergent BioSolutions
OPKO Health
Sangamo BioSciences
Pfizer
Grifols
CSL Behring
Swedish Orphan Biovitrum
By Type:
Type 1
Type 2
Type 3
By Application:
Application 1
Application 2
Application 3
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Hemophilia B Drug Market Overview 2018-2029
-
1.1 China Hemophilia B Drug Industry Development Overview
-
1.2 China Hemophilia B Drug Industry Development History
-
1.3 China Hemophilia B Drug Industry Market Size (2018-2029)
-
1.4 China Hemophilia B Drug Market Analysis by Type from Production Side
-
1.4.1 China Hemophilia B Drug Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)
-
1.4.2 China Hemophilia B Drug Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)
-
1.4.3 China Hemophilia B Drug Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)
-
1.5 China Hemophilia B Drug Market Analysis by Application from Consumption End
-
1.5.1 China Hemophilia B Drug Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
1.5.2 China Hemophilia B Drug Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
1.5.3 China Hemophilia B Drug Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
1.6 China Hemophilia B Drug Market Analysis by Region
-
1.6.1 North China Hemophilia B Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Hemophilia B Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Hemophilia B Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Hemophilia B Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Hemophilia B Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Hemophilia B Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Hemophilia B Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Hemophilia B Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Hemophilia B Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Hemophilia B Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Hemophilia B Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Hemophilia B Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Hemophilia B Drug Industry Development
Chapter 3 Hemophilia B DrugIndustry Chain Analysis
-
3.1 Hemophilia B Drug Industry Chain
-
3.2 Hemophilia B Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Hemophilia B Drug Market
-
3.3 Hemophilia B Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Hemophilia B Drug Market
Chapter 4 China Hemophilia B Drug Market, by Type
-
4.1 China Hemophilia B Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Hemophilia B Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Hemophilia B Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Hemophilia B Drug Production Volume and Growth Rate of Type 1
-
4.5.2 China Hemophilia B Drug Production Volume and Growth Rate of Type 2
-
4.5.3 China Hemophilia B Drug Production Volume and Growth Rate of Type 3
Chapter 5 China Hemophilia B Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Hemophilia B Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Hemophilia B Drug Market Size and Growth Rate, by Application
-
5.5.1 China Hemophilia B Drug Market Size and Growth Rate of Application 1
-
5.5.2 China Hemophilia B Drug Market Size and Growth Rate of Application 2
-
5.5.3 China Hemophilia B Drug Market Size and Growth Rate of Application 3
Chapter 6 China Hemophilia B Drug Market, by Region
-
6.1 China Hemophilia B Drug Production Volume and Production Value, by Region
-
6.2 China Hemophilia B Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Hemophilia B Drug Market Analysis
-
7.1 North China Hemophilia B Drug Market, by Type
-
7.2 North China Hemophilia B Drug Market, by Application
Chapter 8 Central China Hemophilia B Drug Market Analysis
-
8.1 Central China Hemophilia B Drug Market, by Type
-
8.2 Central China Hemophilia B Drug Market, by Application
Chapter 9 South China Hemophilia B Drug Market Analysis
-
9.1 South China Hemophilia B Drug Market, by Type
-
9.2 South China Hemophilia B Drug Market, by Application
Chapter 10 East China Hemophilia B Drug Market Analysis
-
10.1 East China Hemophilia B Drug Market, by Type
-
10.2 East China Hemophilia B Drug Market, by Application
Chapter 11 Northeast China Hemophilia B Drug Market Analysis
-
11.1 Northeast China Hemophilia B Drug Market, by Type
-
11.2 Northeast China Hemophilia B Drug Market, by Application
Chapter 12 Southwest China Hemophilia B Drug Market Analysis
-
12.1 Southwest China Hemophilia B Drug Market, by Type
-
12.2 Southwest China Hemophilia B Drug Market, by Application
Chapter 13 Northwest China Hemophilia B Drug Market Analysis
-
13.1 Northwest China Hemophilia B Drug Market, by Type
-
13.2 Northwest China Hemophilia B Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 Amarna Therapeutics
-
14.1.1 Amarna Therapeutics Company Profile
-
14.1.2 Amarna Therapeutics Hemophilia B Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 UniQure
-
14.2.1 UniQure Company Profile
-
14.2.2 UniQure Hemophilia B Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Dimension Therapeutics
-
14.3.1 Dimension Therapeutics Company Profile
-
14.3.2 Dimension Therapeutics Hemophilia B Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Alnylam Pharmaceuticals
-
14.4.1 Alnylam Pharmaceuticals Company Profile
-
14.4.2 Alnylam Pharmaceuticals Hemophilia B Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Asklepios
-
14.5.1 Asklepios Company Profile
-
14.5.2 Asklepios Hemophilia B Drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Baxter
-
14.6.1 Baxter Company Profile
-
14.6.2 Baxter Hemophilia B Drug Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Spark Therapeutics
-
14.7.1 Spark Therapeutics Company Profile
-
14.7.2 Spark Therapeutics Hemophilia B Drug Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Novo Nordisk
-
14.8.1 Novo Nordisk Company Profile
-
14.8.2 Novo Nordisk Hemophilia B Drug Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 REVO Biologics
-
14.9.1 REVO Biologics Company Profile
-
14.9.2 REVO Biologics Hemophilia B Drug Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Kedrion
-
14.10.1 Kedrion Company Profile
-
14.10.2 Kedrion Hemophilia B Drug Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Emergent BioSolutions
-
14.11.1 Emergent BioSolutions Company Profile
-
14.11.2 Emergent BioSolutions Hemophilia B Drug Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 OPKO Health
-
14.12.1 OPKO Health Company Profile
-
14.12.2 OPKO Health Hemophilia B Drug Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Sangamo BioSciences
-
14.13.1 Sangamo BioSciences Company Profile
-
14.13.2 Sangamo BioSciences Hemophilia B Drug Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Pfizer
-
14.14.1 Pfizer Company Profile
-
14.14.2 Pfizer Hemophilia B Drug Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Grifols
-
14.15.1 Grifols Company Profile
-
14.15.2 Grifols Hemophilia B Drug Market Performance
-
14.15.3 Product&Service Introduction
-
14.16 CSL Behring
-
14.16.1 CSL Behring Company Profile
-
14.16.2 CSL Behring Hemophilia B Drug Market Performance
-
14.16.3 Product&Service Introduction
-
14.17 Swedish Orphan Biovitrum
-
14.17.1 Swedish Orphan Biovitrum Company Profile
-
14.17.2 Swedish Orphan Biovitrum Hemophilia B Drug Market Performance
-
14.17.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Hemophilia B Drug Industry Research Conclusions
-
15.2 Hemophilia B Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Hemophilia B Drug Industry Market Size (2018-2029)
-
Figure China Hemophilia B Drug Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)
-
Figure China Hemophilia B Drug Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)
-
Figure China Hemophilia B Drug Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)
-
Figure China Hemophilia B Drug Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
Figure China Hemophilia B Drug Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
Figure China Hemophilia B Drug Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
Figure North China Hemophilia B Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Hemophilia B Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Hemophilia B Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Hemophilia B Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Hemophilia B Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Hemophilia B Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Hemophilia B Drug Market Size and Growth Rate from 2018-2029
-
Figure Hemophilia B Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Hemophilia B Drug Market Share by Type in 2018
-
Figure China Hemophilia B Drug Market Share by Type in 2023
-
Figure China Hemophilia B Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Hemophilia B Drug Production Volume and Growth Rate of Type 1 (2018-2023)
-
Figure China Hemophilia B Drug Production Volume and Growth Rate of Type 2 (2018-2023)
-
Figure China Hemophilia B Drug Production Volume and Growth Rate of Type 3 (2018-2023)
-
Figure China Hemophilia B Drug Market Share by Application in 2018
-
Figure China Hemophilia B Drug Market Share by Application in 2023
-
Figure China Hemophilia B Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Hemophilia B Drug Market Size and Growth Rate of Application 1 (2018-2023)
-
Figure China Hemophilia B Drug Market Size and Growth Rate of Application 2 (2018-2023)
-
Figure China Hemophilia B Drug Market Size and Growth Rate of Application 3 (2018-2023)
-
Table China Hemophilia B Drug Production Volume by Region (2018-2023)
-
Table China Hemophilia B Drug Production Volume Share by Region (2018-2023)
-
Figure China Hemophilia B Drug Production Volume Share by Region (2018-2023)
-
Table China Hemophilia B Drug Production Value by Region (2018-2023)
-
Table China Hemophilia B Drug Production Value Share by Region (2018-2023)
-
Figure China Hemophilia B Drug Production Value Share by Region (2018-2023)
-
Table China Hemophilia B Drug Sales Volume by Region (2018-2023)
-
Table China Hemophilia B Drug Sales Volume Share by Region (2018-2023)
-
Figure China Hemophilia B Drug Sales Volume Share by Region (2018-2023)
-
Table China Hemophilia B Drug Sales Value by Region (2018-2023)
-
Table China Hemophilia B Drug Sales Value Share by Region (2018-2023)
-
Figure China Hemophilia B Drug Sales Value Share by Region (2018-2023)
-
Table North China Hemophilia B Drug Production Volume by Type (2018-2023)
-
Table North China Hemophilia B Drug Production Volume Share by Type (2018-2023)
-
Figure North China Hemophilia B Drug Production Volume Share by Type (2018-2023)
-
Table North China Hemophilia B Drug Sales Volume by Application (2018-2023)
-
Table North China Hemophilia B Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Hemophilia B Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Hemophilia B Drug Production Volume by Type (2018-2023)
-
Table Central China Hemophilia B Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Hemophilia B Drug Production Volume Share by Type (2018-2023)
-
Table Central China Hemophilia B Drug Sales Volume by Application (2018-2023)
-
Table Central China Hemophilia B Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Hemophilia B Drug Sales Volume Share by Application (2018-2023)
-
Table South China Hemophilia B Drug Production Volume by Type (2018-2023)
-
Table South China Hemophilia B Drug Production Volume Share by Type (2018-2023)
-
Figure South China Hemophilia B Drug Production Volume Share by Type (2018-2023)
-
Table South China Hemophilia B Drug Sales Volume by Application (2018-2023)
-
Table South China Hemophilia B Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Hemophilia B Drug Sales Volume Share by Application (2018-2023)
-
Table East China Hemophilia B Drug Production Volume by Type (2018-2023)
-
Table East China Hemophilia B Drug Production Volume Share by Type (2018-2023)
-
Figure East China Hemophilia B Drug Production Volume Share by Type (2018-2023)
-
Table East China Hemophilia B Drug Sales Volume by Application (2018-2023)
-
Table East China Hemophilia B Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Hemophilia B Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Hemophilia B Drug Production Volume by Type (2018-2023)
-
Table Northeast China Hemophilia B Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Hemophilia B Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Hemophilia B Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Hemophilia B Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Hemophilia B Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Hemophilia B Drug Production Volume by Type (2018-2023)
-
Table Southwest China Hemophilia B Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Hemophilia B Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Hemophilia B Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Hemophilia B Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Hemophilia B Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Hemophilia B Drug Production Volume by Type (2018-2023)
-
Table Northwest China Hemophilia B Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Hemophilia B Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Hemophilia B Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Hemophilia B Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Hemophilia B Drug Sales Volume Share by Application (2018-2023)
-
Table Amarna Therapeutics Company Profile
-
Table Amarna Therapeutics Hemophilia B Drug Revenue, Price and Gross (2018-2023)
-
Table UniQure Company Profile
-
Table UniQure Hemophilia B Drug Revenue, Price and Gross (2018-2023)
-
Table Dimension Therapeutics Company Profile
-
Table Dimension Therapeutics Hemophilia B Drug Revenue, Price and Gross (2018-2023)
-
Table Alnylam Pharmaceuticals Company Profile
-
Table Alnylam Pharmaceuticals Hemophilia B Drug Revenue, Price and Gross (2018-2023)
-
Table Asklepios Company Profile
-
Table Asklepios Hemophilia B Drug Revenue, Price and Gross (2018-2023)
-
Table Baxter Company Profile
-
Table Baxter Hemophilia B Drug Revenue, Price and Gross (2018-2023)
-
Table Spark Therapeutics Company Profile
-
Table Spark Therapeutics Hemophilia B Drug Revenue, Price and Gross (2018-2023)
-
Table Novo Nordisk Company Profile
-
Table Novo Nordisk Hemophilia B Drug Revenue, Price and Gross (2018-2023)
-
Table REVO Biologics Company Profile
-
Table REVO Biologics Hemophilia B Drug Revenue, Price and Gross (2018-2023)
-
Table Kedrion Company Profile
-
Table Kedrion Hemophilia B Drug Revenue, Price and Gross (2018-2023)
-
Table Emergent BioSolutions Company Profile
-
Table Emergent BioSolutions Hemophilia B Drug Revenue, Price and Gross (2018-2023)
-
Table OPKO Health Company Profile
-
Table OPKO Health Hemophilia B Drug Revenue, Price and Gross (2018-2023)
-
Table Sangamo BioSciences Company Profile
-
Table Sangamo BioSciences Hemophilia B Drug Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Hemophilia B Drug Revenue, Price and Gross (2018-2023)
-
Table Grifols Company Profile
-
Table Grifols Hemophilia B Drug Revenue, Price and Gross (2018-2023)
-
Table CSL Behring Company Profile
-
Table CSL Behring Hemophilia B Drug Revenue, Price and Gross (2018-2023)
-
Table Swedish Orphan Biovitrum Company Profile
-
Table Swedish Orphan Biovitrum Hemophilia B Drug Revenue, Price and Gross (2018-2023)
-
